Neoplastic transformation and angiogenesis in the thymus of transgenic mice expressing SV40 T and t antigen under an L-pyruvate kinase promoter (SV12 mice)

International Journal of Experimental Pathology

Volumn 86, Issue 6, 2005, Pages 397-413

  Nabarra, Bernadette ^a,b   Pontoux, Christiane ^a   Godard, Cecile ^a   Osborne Pellegrin, Mary ^a   Ezine, Sophie ^a  

^a Section of Radiology   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Carcinoma; Electron microscopy; Immunochemistry; Neovascularization; Precursor of thymic epithelial cells; Thymic epithelial tumour; Transgenic mice

Indexed keywords

ANGIOGENIC FACTOR; CYTOKERATIN; CYTOKERATIN ANTIBODY; PYRUVATE KINASE; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; IMMUNOCHEMISTRY; MALE; MOLECULAR WEIGHT; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; THYMUS CANCER; THYMUS HYPERPLASIA; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTIGENS, VIRAL, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; MICROSCOPY, IMMUNOELECTRON; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS (GENETICS); PYRUVATE KINASE; THYMUS GLAND; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 28544449967     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2005.00451.x     Document Type: Article

References (97)

1. Adams J.M. & Cory S. (1991) Transgenic models of tumor development. Science 254, 1161-1167.
2. Bennett A.R., Farley A., Blair N.F., Gordon J., Sharp L., Blackburn C.C. (2002) Identification and characterization of thymic epithelial progenitor cells. Immunity 16, 803-814.
3. Berse B., Brown L.F., Van de Water L., Dvorak H.F., Senger D.R. (1992) Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol. Biol. Cell 3, 211-220.
4. Bicknell R. & Harris A.L. (1991) Novel growth regulatory factors and tumor angiogenesis. Eur. J. Cancer 27, 781-785.
5. Blackburn C.C., Augustine C.L., Li R. et al. (1996) The nu gene acts cell-autonomously and is required for differentiation of thymic epithelial progenitors. Proc. Natl. Acad. Sci. USA 93, 5742-5746.
6. Botteri F.M., Van der Putten H., Wong D.F., Sauvage C.A., Evans R.M. (1987) Unexpected thymic hyperplasia in transgenic mice harboring a neuronal promoter fused with simian virus 40 large T antigen. Mol. Cell Biol. 7, 3178-3184.
7. Bouck N. (1992) Angiogenesis: a mechanism by which oncogenes and tumor supressor genes regulate tumorigenesis. Cancer Treat. Res. 63, 359-371.
8. Boyd R.L., Tucek C.L., Godfrey D.I. et al. (1993) The thymic microenvironment. Immunol. Today 14, 445-459.
9. Breier G., Albrecht U., Sterrer S, Risau W. (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-532.
10. Brekelmans P. & Van Ewijk W. (1990) Phenotypic characterization of murine thymic micro-environment. Semin Immunol. 2, 13-24.
11. Brinster R.L., Chen H.Y., Messing A., Van Dyke T., Levine A.J., Palmiter R.D. (1984) Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37, 367-379.
12. Burri P. & Djonov V. (2002) Intussuceptive angiogenesis, the alternative to capillary sprouting. Mol. Aspects Med. 23, S1-S27.
13. Carmeliet P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
14. Cockerill G.W., Gamble J.R., Vadas M.A. (1995) Angiogenesis models and modulators. Int. Rev. Cytol. 159, 113-160.
15. Connolly D.T., Heuvelman D.M., Nelson R. et al. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84, 1470-1478.
16. Cooper D., Schermer A., Sun T.T. (1985) Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab. Invest. 52, 243-256.
17. De Lisser H.M., Christofidou-Solomidou M., Strieter R.M. et al. (1997) Involvement of endothelial PECAM/CD31 in angiogenesis. Am. J. Pathol. 151, 671-677.
18. Debus E., Moll R., Francke W.W., Weber K., Osborn M. (1984) Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am. J. Pathol. 114, 121-130.
19. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular, hyperpermeability and angiogenesis. Am. J. Pathol. 146, 1029-1039.
20. Efrat S., Baekkeskov S., Lane D., Hanahan D. (1987) Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes. EMBO J. 6, 2699-2704.
21. Espinoza G.G. & Azar H.A. (1982) Immunohistochemical localization of keratin-type proteins in epithelial neoplasms. Am. J. Clin. Pathol. 78, 500-507.
22. Ferrara N. (1995) The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat. 36, 127-137.
23. Fina L., Molgaard H.V., Robertson D. et al. (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75, 2417-2426.
24. Folkman J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat. Med. 1, 27-31.
25. Folkman J. & Klagsbrun M. (1987) Angiogenic factors. Science 235, 442-447.
26. Folkman J., Watson K., Ingber D., Hanahan D. (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 359, 58-61.
27. Form D.M., Pratt B.M., Madri J.A. (1986) Endothelial cell proliferation during angiogenesis. In vitro modulation of basement membrane components. Lab. Invest. 55, 521-530.
28. Franke W.W., Schiller D.L., Moll R. et al. (1981) Diversity of cytokeratins: differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J. Mol. Biol. 153, 933-959.
29. Frith C.H., Ward J.M., Chandra M. (1993) The morphology, immunochemistry and incidence of hematopoietic neoplasm in mice and rats. Toxicol. Pathol. 21, 206-218.
30. Fukai I., Masaoka A., Hashimoto T., Yamakawa Y., Mizuno T., Tanamura O. (1993) Cytokeratins in normal thymus and thymic epithelial tumors. Cancer 71, 99-105.
31. Galy A.H., de Waal Malefyt R., Barcena A., Mohan-Peterson S., Spits H. (1993) Untransfected and SV40-transfected fetal and post-natal human thymic stroma cells. Thymus 22, 13-33.
32. + thymic epithelial cells. Nat Immunol. 3, 635-642.
33. Hanahan D. (1986) Oncogenesis in transgenic mice. In: Oncogenes and Growth Control, pp. 349-363. Berlin: Springer Verlag.
34. Hanahan D. (1988) Dissecting multistep tumorigenesis in transgenic mice. Annu. Rev. Genet. 22, 479-519.
35. Hanahan D. (1997) Signaling vascular morphogenesis and maintenance. Science 277, 48-50.
36. Hanahan D. & Folkman J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 335-364.
37. Ho F.C., Fu K.H., Lam S.Y, Chiu S.W., Chan A.C., Muller-Hermelink H.K. (1994) Evaluation of a histogenetic classification for thymic epithelial tumors. Histopathology 25, 21-29.
38. Hoot G.P. & Kettman J.R. (1989) Primary polyoma virus-induced murine thymic epithelial tumors. Am. J. Pathol. 135, 679-695.
39. Hornis T.S., Steinberg M.L., Defendi V., Sun T.T. (1984) Simple epithelial nature of simian virus-40-transformed human epidermal keratinocytes. Cancer Res. 44, 5797-5804.
40. Ingber D.E. & Folkman J. (1989) How does extracellular matrix control capillary morphogenesis. Cell 58, 803-805.
41. Jakeman L.B., Winer J., Bennett G.L., Altar C.A., Ferrara N. (1992) Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissue. J. Clin. Invest. 89, 244-253.
42. Kirchner T. & Muller-Hermelink H.K. (1989) New approaches to the diagnosis of thymic epithelial tumors. Prog. Surg. Pathol. 10, 167-189.
43. Klagsbrun M. & D'Amore P.A. (1991) Regulation of angiogenesis. Annu. Rev. Physiol. 53, 217-239.
44. Klagsbrun M. & Soker S. (1993) VEGF/VPF: the angiogenesis factor found? Current Biol. 10, 699-702.
45. Klug D.B., Carter C., Crouch D., Roop C., Gimenez-Conti C.J., Richie E.R. (1998) Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc. Natl. Acad. Sci. USA 95, 11822-11824.
46. Klug D.B., Carter C., Gimenez-Conti I.B., Richie E.R. (2002) Cutting edge: Thymocyte-independent and thymocyte-dependent phases of epithelial patterning in the fetal thymus. J. Immunol. 169, 2842-2845.
47. Kornstein M. & Deblois G. (1995) Tumors of the thymic epithelial cells. In: Pathology of the Thymus and Mediastinum, Vol. 33, pp. 67-113. (ed. M. Kornstein). Philadelphia: W. Saunders.
48. Kuo T.T. & Chan J.K. (1998) Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Am. J. Surg. Pathol. 22, 1474-1481.
49. Lane D.P. & Crawford L.V. (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278, 261-263.
50. Ledinko N. & Costantino R.L. (1990) Modulation of p53 gene expression of cytokeratin 18 in retinoid-mediated invasion suppressed lung carcinoma cells. Anticancer Res. 10, 1335-1339.
51. Lee S.S., Park W.Y., Chi J.G. et al. (1998) Thymic epithelial tumor progression in an SV40 T transgenic mouse model. Virchows Arch. 432, 33-42.
52. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
53. Levine A.J., Perry M.E., Chang A. et al. (1994) The role of the p53 tumor-suppressor gene in tumorigenesis. Br. J. Cancer 69, 409-116.
54. Longacre T. & Rouse R. (1994) CD31: a new marker for vascular neoplasia. Adv. Anat. Pathol. 1, 16-20.
55. Loning T., Viac J., Caselitz J., Thivolet J., Otto H.F., Seifert G. (1982) Comparative investigation of keratin filaments in normal tissues and tumours of skin, oral mucosa, salivary glands and thymus. Pathol. Res. Pract. 175, 256-265.
56. Ludlow J.W. (1993) Interaction between SV40 large-tumor antigen and the growth suppressor proteins pRb and p53. FASEB J. 5, 866-871.
57. Matsuyama M., Suzuki H., Yamada S., Ito M., Nagayo T. (1975) Ultrastructure of spontaneous and urethan-induced thymomas in Buffalo rats. Cancer Res. 35, 2771-2779.
58. McCarthy S.A., Symonds H.S., Van Dyke T. (1994) Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. Proc. Natl. Acad. Sci. USA 91, 3979-3983.
59. Messing A., Pinkert C.A., Palmiter R.D., Brinster R.L. (1988) Developmental study of SV40 large T antigen expression in transgenic mice with choroid plexus neoplasia. Oncogene Res. 3, 87-97.
60. Millauer B., Wizigmann-Voos S., Schnurch H. et al. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
61. Moll J., Eibel H., Botteri F., Sansig G., Regnier C., van der Putten H. (1992) Transgenes encoding mutant simian virus 40 large T antigens unmask phenotypic and functional constraints in thymic epithelial cells. Oncogene 7, 2175-2187.
62. Moll R., Krepler R., Franke W.W. (1983) Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 23, 256-269.
63. Moroco J.R., Solt D.B., Polverini P.J. (1990) Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. Lab. Invest. 63, 298-306.
64. Muller-Hermelink H., Marx A., Kirchner T. (1994) Advances in the diagnosis and classification of thymic epithelial tumors. Rec. Adv. Histopathol. 16, 49-72.
65. Murray A.B., Schaffer E., Nussel M., LuZ. A. (1985) Incidence, morphology and ultrastructure of spontaneous thymoma, the most common neoplasm in W/Nhg rats. J. Natl. Cancer Inst 75, 369-379.
66. Nabarra B. & Andrianarison I. (1987) Ultrastructural studies of thymic reticulum. I. Epithelial components. Thymus 9, 95-121.
67. Nabarra B., Mulotte M., Casanova M., Godard C., London J. (2001) Ultrastructural study of the FVB/N mouse thymus: presence of an immature epithelial cell in the medulla and premature involution. Dev. Comp. Immunol. 25, 231-243.
68. (Erratum in Dev. Comp. Immunol. 25, 539-543).
69. Nabarra B., Martinon C., Godard C. et al. (2002) Early steps of a thymic tumor in SV40 transgenic mice: hyperplasia of medullary epithelial cells and increased mature thymocyte number disturb thymic export. Dev. Immunol. 9, 223-231.
70. Naylor D.C., Krinke G.J., Ruefenacht H.J. (1988) Primary tumors of the thymus in the rat. J. Comp. Pathol. 99, 187-203.
71. Neufeld G., Tessler S., Gitay-Goren H., Cohen T., Levi B.Z. (1994) Vascular endothelial growth factor and its receptors. Prog. Growth Fact. Res. 5, 89-97.
72. Palmiter R., Chen H.Y., Messing A., Brinster R.L. (1985) SV40 enhancer and large T antigen are instrumental in development of choroid plexus tumors in transgenic mice. Nature 316, 457-460.
73. Park W.Y., Kim J.I., Shim E.H. et al. (1996) Development of thymic carcinoma in transgenic mice expressing SV40 T antigen. Cancer Lett. 107, 293-300.
74. Plate K.H., Breir G., Weich H.A., Risau W. (1992) Vascular endothelial growth is a potential tumor angiogenesis factor in vivo. Nature 359, 845-848.
75. Quinn T.P., Peters K.G., De Vries C., Ferrara N., Williams L.T. (1993) Fetal liver kinase-1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533-7537.
76. Rak J., Filmus J., Finkenzeller G., Grugel S., Marme D., Kerbel R.S. (1995) Oncogenes as inductors of tumor angiogenesis. Cancer Metastasis Rev. 14, 263-277.
77. Ramaekers F., Huysmans A., Moesker O., Schaart O., Herman C., Vooijs P. (1985) Cytokeratin expression during neoplastic progression of human transitional cell carcinomas as detetected by monoclonal and polyclonal antibodies. Lab. Invest. 52, 31-38.
78. Reynolds R.K., Hoekzema G.S., Vogel J., Hinrichs S.H., Jay G. (1988) Multiple endocrine neoplasia induced by the promiscuous expression of a viral oncogen. Proc. Natl. Acad. Sci. USA 85, 3135-3139.
79. Risau W. (1991) Vasculogenesis, angiogenesis and endothelial cell differentiation during embryonic development. In: The Development of Vascular System, pp. 58-68. (eds. R. Feinberg, G. Sherer, R. Auerbach). Basel: Karger.
80. Rosai J. & Levine G. (1976) Tumors of the thymus. In: Atlas of Tumor Pathology, Vol. 13. Washington, DC: Armed Forces Institute of Pathology.
81. Saenz-Robles M.T., Symonds H., Chen J., Van Dyke T. (1994) Induction versus progression of brain tumor development: differential functions for pRb- and p53-targeting domains of simian virus 40 T antigen. Mol. Cell Biol. 14, 2686-2698.
82. Savino W. & Dardenne M. (1988) Immunohistochemical studies on a human thymic epithelial cell subset defined by the anticytokeratin 18 monoclonal antibody. Cell Tissue Res. 254, 225-231.
83. Schlingemann R.O., Rietveld F.J., de Waal R.M. et al. (1990) Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab. Invest. 62, 690-696.
84. Schor A.M. & Schor S.L. (1983) Tumor angiogenesis. J. Pathol. 141, 385-413.
85. Senger D.R., Van de Water L., Brown L.F. (1993) Vascular permeability factor (VPF/VEGF) in tumor biology. Cancer Metastasis Rev. 12, 303-324.
86. Sepulveda A.R., Finegold M.J., Smith B. et al. (1989) Development of a transgenic mouse system for the analysis of stages in liver carcinoma genesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Cancer Res. 49, 6108-6117.
87. Shalaby F., Ho J., Standford W.L. et al. (1997) A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89, 981-990.
88. Small J.A., Blair D.G., Showalter S.D., Scangos G.A. (1985) Analysis of a transgenic mouse containing SV40 and v-myc sequence. Mol. Cell. Biol. 5, 642-648.
89. Suster S. & Moran C.A. (1998) Thymic carcinoma: spectrum of differentiation and histologic types. Pathology 30, 111-122.
90. Suster S. & Moran C.A. (1999) Primary thymic epithelial neoplasms: spectrum of differentiation and histological features. Semin. Diagn. Pathol. 16, 2-17.
91. Tamano S., Hagiwara A., Shibata M.A., Kurata Y., Fukushima S., Ito N. (1988) Spontaneous tumors in aging (C57BL/6N × C3H/HeN) F1 (B6C3F1) mice. Toxicol. Pathol. 16, 321-326.
92. Teitz. T., Chang J.C., Kan Y.W., Yen T.S. (1995) Thymic epithelial neoplasm in transgenic mice expressing SV40 T antigen under the control of an erythroid-specific enhancer. J. Pathol. 177, 309-315.
93. Thomas P., Said J.W., Nash G., Banks-Schlegel S. (1984) Profiles of keratin proteins in basal and squamous cell carcinomas in the skin. An immunohistochemical study. Lab. Invest. 50, 36-41.
94. Truong L.D., Mody D.R., Cagle P.T., Jackson-York G.L., Schwartz M.R., Wheeler T.M. (1990) Thymic carcinoma. A clinicopathologic study of 13 cases. Am. J. Surg. Pathol. 14, 151-166.
95. Tseng S.C., Jarvinen M.J., Nelson W.G., Huang J.W., Woodcock-Mitchell J., Sun T.T. (1982) Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell 30, 361-372.
96. Van Dyke T.A., Finlay C., Miller D., Marks J., Lozano G., Levine A.J. (1987) Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice. J. Virol. 61, 2029-2032.
97. Ward J.M. & Rehm S. (1990) Applications of immunohistochemistry in rodent tumor pathology. Exp. Pathol. 40, 301-312.